S'abonner

The Relationship Between Anxiety and Overactive Bladder or Urinary Incontinence Symptoms in the Clinical Population - 19/04/17

Doi : 10.1016/j.urology.2016.07.013 
H. Henry Lai a, b, * , Amar Rawal a, Baixin Shen a, Joel Vetter a
a Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St Louis, MO 
b Department of Anesthesiology, Washington University School of Medicine, St Louis, MO 

*Address correspondence to: H. Henry Lai, M.D., Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, 4960 Children's Place, Campus Box 8242, St Louis, MO 63110.Division of Urologic SurgeryDepartment of SurgeryWashington University School of Medicine4960 Children's Place, Campus Box 8242St LouisMO63110

Abstract

Objective

To investigate the relationship between anxiety and overactive bladder (OAB) or urinary incontinence symptoms among clinical population.

Materials and Methods

Patients who were diagnosed with OAB and age-matched control subjects without OAB were enrolled. Anxiety symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS-A). OAB or incontinence symptoms were assessed using the International Consultation on Incontinence—Urinary Incontinence Short Form (ICIQ-UI), ICIQ-OAB, Urogenital Distress Inventory Short Form (UDI-6), Incontinence Impact Questionnaire Short Form (IIQ-7), and OAB-q. Other psychosocial factors were also assessed.

Results

About half of the OAB subjects (48%) had anxiety symptoms, and one quarter of OAB subjects (24%) had moderate to severe anxiety. OAB subjects reported significantly higher anxiety symptoms compared to age-matched controls (HADS-A: 7.5 ± 4.5 vs 3.3 ± 3.6, P < .001). OAB subjects with anxiety reported more severe OAB or incontinence symptoms, and greater bother and impact on quality of life compared to OAB subjects without anxiety (ICIQ-UI, ICIQ-OAB, UDI-6, IIQ-7, OAB-q, P values all <.05). OAB subjects with anxiety also have more psychosocial difficulties (eg, more depression, higher stress levels). Among OAB subjects, there were positive correlations between the severity of anxiety symptoms and the severity of OAB/incontinence symptoms (Spearman's correlation coefficients 0.29 to 0.47, P < .05). OAB subjects with both anxiety and depression reported higher ICIQ-UI and IIQ-7 scores than those who had anxiety but no depression (P = .014, .025 respectively).

Conclusion

OAB patients reported higher anxiety symptoms compared to controls. OAB patients with anxiety reported more severe OAB or incontinence symptoms, worse quality of life, and more psychosocial difficulties compared to OAB patients without anxiety. There are positive correlations between the severity of anxiety symptoms and OAB or incontinence symptoms.

Le texte complet de cet article est disponible en PDF.

Plan


 Financial Disclosure: Dr. Lai is a study investigator for Allergan and Medtronic. The remaining authors declare that they have no relevant financial interests.
 Funding Support: The study was partly supported by the National Institutes of Health grants P20-DK-097798 and K08-DK-094964. Research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.


© 2016  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 98

P. 50-57 - décembre 2016 Retour au numéro
Article précédent Article précédent
  • Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion
  • Jia-Fong Jhang, Yung-Hsiang Hsu, Hann-Chorng Kuo
| Article suivant Article suivant
  • Early Stage Bladder Cancer: Do Pathology Reports Tell Us What We Need to Know?
  • Florian R. Schroeck, Erik A. Pattison, Daniel W. Denhalter, Olga V. Patterson, Scott L. DuVall, John D. Seigne, Douglas J. Robertson, Brenda Sirovich, Philip P. Goodney

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.